DMPA-SC Self-Injection Best Practices project brief

Subcutaneous DMPA (DMPA-SC, Sayana® Press) is a new, easy-to-use injectable contraceptive that is ideally suited for remote access and even self-injection. This brief provides an overview of PATH’s Self-Injection Best Practices project, which aims to evaluate and identify optimal program models for DMPA-SC self-injection. For more information, please visit Self-injection best practices: designing family planning programs that work or email FPoptions@path.org.

Publication date: October 2017

Available materials

  1. English

    1. Self-Injection Best Practices Project: Uganda 644.1 KB PDF

      Hard copies are not available.

  2. French

    1. Self-Injection Best Practices Project: Uganda [French] 732.7 KB PDF

      Hard copies are not available.